多囊卵巢综合征新型脂质谱的发现:胰岛素与雄激素是否反向调控生物活性脂质生成
研究采用脂质组学比较32例新诊断多囊卵巢综合征(PCOS)女性与34例对照(各分肥胖与瘦亚组)的血清脂质谱,并用PCOS大鼠模型验证。肥胖PCOS患者磷脂酰胆碱升高、溶血磷脂降低,长链饱和脂肪酸升高、多不饱和脂肪酸(PUFA)降低;肥胖对照中花生四烯酸下游生物活性脂质升高,但在肥胖与瘦PCOS患者中均低于各自对照。作者认为胰岛素与雄激素可能对PCOS脂质谱产生相反作用。
要点
- 肥胖PCOS患者较瘦对照磷脂酰胆碱升高、溶血磷脂降低
- 肥胖PCOS患者较瘦对照PUFA降低、长链饱和脂肪酸升高
- 花生四烯酸下游生物活性脂质在肥胖对照升高,在肥胖与瘦PCOS患者均低于各自对照
核心结论
- PCOS患者存在磷脂酰胆碱、游离脂肪酸及PUFA代谢物水平异常。
- 循环胰岛素与雄激素可能对PCOS患者脂质谱、尤其对来源于PUFA的生物活性脂质代谢物产生相反作用。
- 这些临床观察需进一步研究PCOS与肥胖的分子机制和临床意义。
研究设计与样本
- 研究纳入32例新诊断PCOS女性与34例对照,分为肥胖与瘦亚组。
- 采用气相色谱-质谱(MS)与液相色谱-MS分析血清磷脂、游离脂肪酸及生物活性脂质。
- 使用PCOS大鼠模型验证人体研究结果。
主要发现
- 肥胖PCOS患者较瘦对照磷脂酰胆碱升高、溶血磷脂降低。
- 肥胖PCOS患者较瘦对照PUFA水平降低、长链饱和脂肪酸水平升高。
- 花生四烯酸下游血清生物活性脂质在肥胖对照升高,但在肥胖与瘦PCOS患者中均低于各自对照。
局限性
- 原文在结论中提出这些临床观察需进一步研究PCOS与肥胖的分子机制和临床意义。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Polycystic ovary syndrome (PCOS) is a complex syndrome showing clinical features of an endocrine/metabolic disorder, including hyperinsulinemia and hyperandrogenism. Polyunsaturated fatty acids (PUFAs) and their derivatives, both tightly linked to PCOS and obesity, play important roles in inflammation and reproduction. OBJECTIVE: This study aimed to investigate serum lipid profiles in newly diagnosed patients with PCOS using lipidomics and correlate these features with the hyperinsulinemia and hyperandrogenism associated with PCOS and obesity. DESIGN AND SETTING: Thirty-two newly diagnosed women with PCOS and 34 controls were divided into obese and lean subgroups. A PCOS rat model was used to validate results of the human studies. MAIN OUTCOME MEASURES: Serum lipid profiles, including phospholipids, free fatty acids (FFAs), and bioactive lipids, were analyzed using gas chromatography-mass spectrometry (MS) and liquid chromatography-MS. RESULTS: Elevation in phosphatidylcholine and a concomitant decrease in lysophospholipid were found in obese patients with PCOS vs lean controls. Obese patients with PCOS had decreased PUFA levels and increased levels of long-chain saturated fatty acids vs lean controls. Serum bioactive lipids downstream of arachidonic acid were increased in obese controls, but reduced in both obese and lean patients with PCOS vs their respective controls. CONCLUSIONS: Patients with PCOS showed abnormal levels of phosphatidylcholine, FFAs, and PUFA metabolites. Circulating insulin and androgens may have opposing effects on lipid profiles in patients with PCOS, particularly on the bioactive lipid metabolites derived from PUFAs. These clinical observations warrant further studies of the molecular mechanisms and clinical implications of PCOS and obesity.
引用
- Li S, Chu Q, Ma J, et al. Discovery of Novel Lipid Profiles in PCOS: Do Insulin and Androgen Oppositely Regulate Bioactive Lipid Production? J Clin Endocrinol Metab. 2017. PMID: 27886515. doi:10.1210/jc.2016-2692
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。